SecBot SecBot
EFFECT ·Filed Aug 20, 2026

YARW

Yarrow Bioscience, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed2mo ago SEC9999999995-26-002706
IPO/offering going effective
Actionable Insight ▼ Bearish

Monitor for any takedown notices or prospectus supplements indicating an actual offering. The shelf being effective means management can act quickly — watch for overnight offerings or ATM programs that would pressure the stock.

DirectionBearish
Confidencemedium
Horizonweeks
Latest settled — T+20d
YARW ▼ -23.32% at T+20d
SHORT call ✓ call won +23.32% · α vs SPY +23.32% · entry $38.20 → $29.29
Next anchor: T+60d in 17d
Latest observation: T+45 +69.30% FF3 residual α
Entry = T+0 close
Aug 20, 2026
via day close
T+1d
-4.65%
call +4.65% · α +5.06%
$36.43
settled 2mo ago
T+5d
-0.52%
call +0.52% · α +1.64%
$38.00
settled 2mo ago
T+20d
-23.32%
call +23.32% · α +23.32%
$29.29
settled 6w ago
T+60d
Pending
in 17d

Price Chart

Loading chart...

Executive Summary

Yarrow Bioscience's shelf registration statement (File No. 333-277609) became effective on August 19, 2026. This allows the company to sell securities from time to time, creating a potential dilution overhang for existing common shareholders. The effectiveness follows a POS AM filing, indicating the shelf was amended before going effective.

Key Facts

  • Shelf registration (333-277609) declared effective on 2026-08-19
  • Company can now offer and sell securities at any time
  • Preceded by a POS AM (post-effective amendment) filing
  • Market cap is $108M, making potential dilution material
  • Company has undergone multiple name changes (VYNE Therapeutics, Menlo Therapeutics)

Financial Impact

Potential dilution from future offerings; no specific dollar amount disclosed

dilutionshare count

Risk Factors

  • Dilution risk from future share issuance
  • No stated use of proceeds or offering size — uncertainty about capital needs
  • Company has a history of name changes, which may signal prior restructuring

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002706
Document: 9999999995-26-002706-index.html9999999995-26-002706
Document: 9999999995-26-002706.txt9999999995-26-002706
3 reports for YARW
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for YARW — sortable, filterable
TypeNow
Sep 17, 2026
5w ago
SC 13G
NEUTRAL ★ 3/10
$29.29 $18.31▼ −37.49%▼ −37.69%$20.00 (−31.72%)
Sep 11, 2026
6w ago
424B5
BEARISH ★ 7/10
$26.26 $19.82▲ +24.52%▲ +26.79%$20.00 (+23.84%)
Aug 20, 2026
9w ago
EFFECT
BEARISH ★ 5/10
$38.20 $29.29▲ +23.32%▲ +23.32%$20.00 (+47.64%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 4h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 20, 2026